Public health experts warned the U.S. to brace for a difficult flu season. There are two main reasons for concern: Waning COVID restrictions on mask-wearing and diminished immunity in the wake of two mild flu seasons. (The Hill)
The Centers for Disease Control and Prevention said the U.S. monkeypox outbreak is slowing. There is a decline in the growth of monkeypox across the country, where there are more than 22,000 confirmed cases, though it is still increasing in certain regions of the U.S. (CNBC)
Supply of Adderall is running low at CVS and Walgreens as demand soars. The widely-used ADHD drug is experiencing shortages across the U.S., according to major pharmacy chains and interviews with patients. (Bloomberg)
Analysts said AstraZeneca, Eli Lilly and Roche are among the pharmaceutical companies upgraded for high returns on R&D investments. The drugmakers have weathered the uncertain macroeconomic market and garnered investor attention since the start of the year. (MarketWatch)
There is a boom among men undergoing a radical and expensive leg-lengthening surgery to grow three to six inches taller. The only catch? That it requires having both of the patient’s femurs broken. (GQ)
